Medicine composition for treating infantile viral myocarditis

A technology for viral myocarditis and a composition is applied in the field of pharmaceutical compositions for the treatment of viral myocarditis in children, and can solve problems such as poor specificity of auxiliary examinations, great disparity in severity of illness, and difficulties in clinical diagnosis and treatment.

Inactive Publication Date: 2015-03-25
榆林市第一医院
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] The incidence of viral myocarditis (VM) has increased significantly in recent years, posing a serious threat to children's health. Because of its various clinical manifestations, varying degrees of severity, and poor specificity of auxiliary examinations, it has brought certain difficulties to clinical diagnosis and treatment.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Medicine composition for treating infantile viral myocarditis
  • Medicine composition for treating infantile viral myocarditis

Examples

Experimental program
Comparison scheme
Effect test

experiment example

[0015] normal information

[0016] Collected 50 cases of children who visited our hospital from February 2013 to March 2014, including 25 males and 25 females, aged 5-12 years, with an average of 7.1 years; the course of disease was 8-42 days, with an average of 25 days.

[0017] Diagnosis and Inclusion Criteria

[0018] The diagnostic criteria refer to the diagnostic criteria for viral myocarditis revised by the National Pediatric Cardiology Academic Conference in Kunming, September 1999 (the diagnostic criteria for viral myocarditis of the Cardiovascular Group of the Pediatric Branch of the Chinese Medical Association [J] Chinese Journal of Pediatrics, 2000, 38 (2) :2).

[0019] Inclusion criteria: 1) age 5-12 years old, taking traditional Chinese medicine decoction; 2) clinical complaints of palpitations and fatigue; 3) heart enlargement (one of the manifestations of X-ray and echocardiography); 4) electrocardiogram changes, with ST-T changes in 2 or more major leads (I, ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to a medicine composition for treating infantile viral myocarditis. The medicine composition comprises cassia twig, liquorice, orange peel, chaff flower root, glossy privet fruits, phellinus, cistanche, soroseris gillii, white peony roots and the like. Chinese medicinal materials are selected to prepare the medicine composition for treating infantile viral myocarditis, myocardial metabolism can be improved, heart muscles are nourished, heart cells are protected, the disease resistance of the heart muscles is improved, viruses can be directly killed, damage to the heart muscles caused by the viruses is relieved, anti-virus and integral regulation combined action effects are achieved, side effects of long-term application of western medicines on human bodies are relieved, the medicine composition is an ideal medicine for treating the myocarditis, contains a large number of active components and can be extensively applied to clinical practice, raw materials are cheap, and a preparation method is simple.

Description

[0001] The present invention is a divisional application of a patent with the application number 2014103933369, the application date is August 12, 2014, and the invention title is "a pharmaceutical composition for treating viral myocarditis in children". technical field [0002] The invention relates to the field of pediatrics, in particular to a pharmaceutical composition for treating children with viral myocarditis. Background technique [0003] The incidence of viral myocarditis (VM) has increased significantly in recent years, posing a serious threat to children's health. Because of its various clinical manifestations, varying degrees of severity, and poor specificity of auxiliary examinations, it has brought certain difficulties to clinical diagnosis and treatment. In recent years, due to the wide application of antibiotics, the incidence of rheumatic myocarditis has decreased significantly, but the incidence of viral myocarditis has increased. According to scientific r...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/752A61K36/896A61P9/00A61P31/12
CPCA61K9/0095A61K36/07A61K36/185A61K36/21A61K36/28A61K36/355A61K36/41A61K36/48A61K36/484A61K36/53A61K36/54A61K36/638A61K36/64A61K36/71A61K36/73A61K36/752A61K36/89A61K36/896A61K2300/00
Inventor 郝红娟
Owner 榆林市第一医院
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap